Great Deal! Get Instant $10 FREE in Account on First Order + 10% Cashback on Every Order Order Now

������������������ � �� ���� ������������������� � ����������� ���!�� �� �"���� #������ ����$%� &��"������� �'��&�'����������� ������()�(*��+���, �������**�(*!*�-��� ��. / XXXXXXXXXX 9:; ?;@ABCDE...

1 answer below »

������������������ �    
��
����
�������������������    �
����������� ���!��    ��
�"����
#������
����$%�
&��"�������    �'��&�'�����������
������()�(*��+���,
�������**�(*!*�-��� ��.
XXXXXXXXXX
9:;<=>?;@ABCDEJJ;KDLB:?:O;EBL@DD?P
Q:MJGRD;S:M:E>MJ;M:K;>:TD??>B:?;<=M<;MKK;TMJHD;RMUB:
Q:MJGRD;S:M:E>:O;B@UB:?;L>RD;>:TD?W635XY70
ZBH;MAD;M;S:M:E>MJ;M:MJG?<;NBA;<=D;E=B?D:;[H?>:D??;<=M<;GBH;?DJDE:O;GBHA;\BKHJD;]IB;̂BHA:MJ;M??>O:LD:<_;ZBHA;?H@DAT>?BA;=M?;K>?EBTDADK;JM?<;L>:H:D??̀?;[BMAK;BN;K>ADE?
JBBa>:O;NBA;H@KM:D??̀?;S:M:E>MJ;=DMJ<=_;ZBHA;?H@DAT>?BA;=M?;M?aDK;GBH;D;M;AD@BA<;ADOMAK>:O;<=D;[H?>:D??̀?;EHAAD:<;S:M:E>MJ;=DMJ<=;M:K;<=D;MTM>JM[JD;S:M:E>MJ;B@UB:?;NBA;>L@ABT>:O;<=D
[H?>:D??_;ZBH̀TD;MJ?B;[DD:;M?aDK;E=;B@UB:?;<=D;[H?>:D??;?=BHJK;E=BB?D;?;S:M:E>MJ;=DMJ<=_;ZBHA;?H@DAT>?BA;I>JJ;<=D:;H?D;GBHA;AD@BA<;[H?>:D??̀?;[BMAK;BN;K>ADE:O;JDTDJ?;BN;a:BIJDKOD;>:;7Y36c058
d?>:O;<=D;[H?>:D??;GBH;E=B?D;NABL;<=D;eABCDE<;]IB;fH?>:D??;g@UB:?;h>??BA;=;<=D;[BMAK;BN;K>ADE:O;<=D>A;@AD?D::;L>:K;<=M<;GBHA;AD@BA
:DDK?;J>MA;I
=;S:M:ED;:D??;NHJJG;H:KDA?d?>:O;\DAOD:<;g:J>:DF;JBEMMJ;??;<=ABHO=BH<;<=D;@ABCDE<_;kDNDA;l>:M:E>MJ;Q??HL@UB:?;KBEHLD:<;JBEM:;<=D;mH@@BAU:O;\MMJ?;?DEUB:;NBA;<=D;M??HL@UB:?;GBH;:DDK;>:;BAKDA;JM[JD;S:M:E>MJ;B@UB:?;BH:DK;>:;<=D;l>:M:E>MJ;Q:MJG?>?;?DEUB:
BN;<=D;@ABCDE<;K>ADEUB:?_
ZBH;MAD;D:EBHAMODK;:M:E>MJ;Q:MJG?<;kD@BA<;:;<=D;n=M<;;?DEUB:;?;@ABCDE<_
m@DE>SEMJJGF;GBH;LH?<;MKKAD??;<=D;NBJJBI>:OP
o_;p75X567Xqrs5Xqt878P;9:;<=>?;?DEUB:;BN;<=D;AD@BAJJ;H?D;<=D;LB?<;ADED:<;jHMAMJ;?:D??;M:K;<=D;eABCDE<;]IB;l>:M:E>MJ;lBALHJM?;?@ADMK?=DD<;uJBEM:
=D;n=M<;;?DEUB:v;MMJ;NBALHJM?;NBA;M??D??>:O;<=D;[H?>:D??̀?;S:M:E>MJ;=DMJ<=_;ZBH;I>JJ;MJ?B;M:MJGRD;MJJ;<=ADD;MTM>JM[JD;S:M:E>MJ;B@UB:?;NBA;>L@ABT>:O;<=D
[H?>:D??;[M?DK;B:;GBHA;EMJEHJMUB:?;M:K;<=D;@ABT>KDK;eABCDE<;]IB;l>:M:E>MJ;Q??HL@UB:?;KBEHLD:<_
Q_;p75X567Xq
Xq6wqXc058P;xMJEHJMMJ;NBALHJM?;:D??̀?;EHAAD:<;S:M:E>MJ;=DMJ<=_;m@DE>SEMJJGF;GBH;LH?<;EMJEHJM:OP
nBAa>:O;EM@
MJ
xHAAD:<;AMUB
yD[<;AMUB
zMA:>:O?;@DA;?=MAD
eA>ED{DMA:>:O?;AMUB
]Bl>:M:E>MJ;JDTDAMOD
|D<;@ABS<;LMAO>:
kDkDG
f_;}0Y~75
X274Xqr€X5X31354P;zV@JM>:;<=D;>L@ME<;BN;IBAa>:O;EM@
MJ;LM:MODLD:<;B:;<=D;[H?>:D??̀?;B@DAMUB:?_;eABT>KD;DVML@JD?;L?_
x_;05‚rƒ5„3841354P;Q:MJGRD;<=D;A>?a?;M:K;[D:DS:D??;E=BB?>:O;:TD?<;>:;M;EBA@BAM:EJHK>:O;<=D;:DED??MAG;D<=>EMJ;EB:?>KDAMUB:?F;M@@AB@A>MDVML@JD?;?_
y_;/X274Xqr…†w721354P;Q:MJGRD;<=D;A>?a?;M:K;[D:DS:D??;E=BB?>:O;:TD?<;>:;EM@
MJ;DjH>@LD::EJHK>:O;<=D;:DED??MAG;D<=>EMJ;EB:?>KDAMUB:?F;M@@AB@A>MDVML@JD?;?_
‡ˆ
������������������ �    
��
����
�������������������    �
����������� ���!��    ��
�"����
#������
����$%�
&��"�������    �'��&�'�����������
������()�(*��+���,
�������**�(*!*�-��� ��.
XXXXXXXXXX:3;:<1=>?@ABC1DEC1FGHIH1?>J1KC>CLDH1MN1DEC1KOHG>CHH1PEMMHG>Q1DM1ROFPE?HC1?1P?RGD?@1@C?HCS1G>P@OJG>Q1DEC1>CPCHH?FA1CDEGP?@1PM>HGJCF?TM>HS1?RRFMRFG?DC1P?@PO@?TM>HS1?>J1CU?VR@CH1DM
HORRMFD1AMOF1?>?@AHGH0
W01X5Y3YZ5378[\37]3̂_Y<1̀>1DEGH1HCPTM>1MN1DEC1FCRMFDS1AMO1aG@@1>Ma1JCDCFVG>C1GN1DEC1DEFCC1?b?G@?K@C1L>?>PG?@1MRTM>H1G>1DEC1cFMdCPD1eaM1fG>?>PG?@1=HHOVRTM>H1JMPOVC>D1?FC1?RRFMRFG?DC1NMF1DEC1KOHG>CHHS
PM>HGJCFG>Q1DEC1?>?@AHGH1AMO1JGJ1G>1DEC1LFHD1HCPTM>01gMO1aG@@1?@HM1CUR@?G>1L>?>PG>Q1?>J1JCHPFGKC1DEC1KOHG>CHHhH1@GIC@A1NODOFC1RCFNMFV?>PC0
=01X5Y3YZ5Yi<1/UR@?G>1EMa1?1KOHG>CHH1L>?>PCH1GDH1MRCF?TM>H1?>J1CUR?>HGM>0
j01k_Yl8mY\:;6n:Y6<1=HHCHH1DEC1?RRFMRFG?DC>CHH1MN1?1KM>J1G
CHDVC>D1?H1?1L>?>PG>Q1MRTM>1NMF1DEC1KOHG>CHHoH1L>?>PG?@1EC?@DES1OHG>Q1AMOF1L>?>PG?@1?>?@AHGH1?>J1MDECF1L>?>PG?@1G>NMFV?TM>1DM
AMOF1HORRMFD1P@?GVH0
p XXXXXXXXXX[q]54n:Y6<1=HHCHH1DEC1?RRFMRFG?DC>CHH1MN1?1P?RGD?@1CrOGRVC>D1G
CHDVC>D1?H1?1L>?>PG>Q1MRTM>1NMF1DEC1KOHG>CHHoH1L>?>PG?@1EC?@DES1OHG>Q1AMOF1L>?>PG?@1?>?@AHGH1?>J1MDECF1L>?>PG?@
G>NMFV?TM>1DM1HORRMFD1AMOF1P@?GVH0
s XXXXXXXXXX:3;:<1=HHCHH1DEC1?RRFMRFG?DC>CHH1MN1?1P?RGD?@1@C?HC1ROFPE?HC1?H1?1L>?>PG>Q1MRTM>1NMF1DEC1KOHG>CHHoH1L>?>PG?@1EC?@DES1OHG>Q1AMOF1L>?>PG?@1?>?@AHGH1?>J1MDECF1L>?>PG?@1G>NMFV?TM>1DM
HORRMFD1AMOF1P@?GVH0
01tu_v6wx:vn8X5Y3YZ5Yi<1/UR@?G>1EMa1RMDC>T?@1HEMFDyDCFV1L>?>PG>Q1HMOFPCH1PMO@J1EC@R1DEC1KOHG>CHH1F?GHC1>CCJCJ1NO>JH1NMF1GVRFMbG>Q1GDH1L>?>PG?@1EC?@DE01j?HC1AMOF1FCHRM>HC1M>1DEC1KOHG>CHHoH
POFFC>D1L>?>PG?@1G>NMFV?TM>0
f01X]6]v:8X5Y3YZ53782_Y;5l:v3̂_Y;<1sCHPFGKC1DEC1KOHG>CHHoH1@GIC@A1NODOFC1L>?>PG?@1RCFNMFV?>PC1K?HCJ1M>1GDH1POFFC>D1L>?>PG?@1aC@@yKCG>Q1?>J1FGHI1@CbC@H01zHC1L>?>PG?@1G>NMFV?TM>1DM1HORRMFD1AMOF
P@?GVH0
{01X5Y3YZ5378|:Z_nn:Yl3̂_Y;<1̀>1DEGH1HCPTM>1MN1DEC1FCRMFDS1AMO1aG@@1FCPMVVC>J1aEGPE1L>?>PG>Q1MRTM>}H~1?FC1DEC1KCHD1NMF1DEC1KOHG>CHH1DM1PEMMHC1JCRC>JG>Q1M>1GDH1L>?>PG?@1EC?@DE0
=01X5Y3YZ5378|:Z_nn:Yl3̂_Y;€<1CPMVVC>J1DEC1VMHD1?RRFMRFG?DC1L>?>PG>Q1MRTM>}H~1K?HCJ1M>1DEC1KOHG>CHHoH1L>?>PG?@1EC?@DES1G>P@OJG>Q1?1F?TM>?@C1NMF1aEA1DEC1MRTM>}H~1?FC1KCHD0
‚u3686_8t]ƒn56
eM1PMVR@CDC1DEGH1RFMdCPDS1AMO1VOHD1HOKVGD1DEC1NM@@MaG>Q
X5Y3YZ5378„Y37…;5;8|:4_v61
†OKVGD1AMOF1PMVR@CDCJ1FCRMFD1?H1?1{y1DM1‡yR?QC1ˆMFJ1JMPOVC>D1aGDE1‰WyRMG>D1eGVCH1ŠCa1MV?>1NM>DS1JMOK@C1HR?PG>QS1?>J1M>CyG>PE1V?FQG>H01‹FS1AMO1V?A1OHC1DEC1RFMbGJCJ1cFMdCPD1eaM1fG>?>PG?@1=>?@AHD
CRMFD1ˆMFJ1sMPOVC>D1DCVR@?DC1GN1AMO1HM1PEMMHC1DM1EC@R1AMO1PMVR@CDC1AMOF1FCRMFD0
gMO1aG@@1?@HM1>CCJ1DM1HOKVGD1DEC1/UPC@1L@CH1NMF1AMOF1PEMHC>1KOHG>CHHoH1K?@?>PC1HECCDS1G>PMVC1HD?DCVC>DS1?>J1P?HE1ŒMa1HD?DCVC>D1NFMV1CFQC>D1‹>@G>C0
t4v:3l;u::6<1cFMdCPD1eaM1fG>?>PG?@1fMFVO@?H1†RFC?JHECCD1
zHC1DEGH1/UPC@1HRFC?JHECCD1DM1PMVR@CDC1AMOF1P?@PO@?TM>H1NMF1DEC1RFMdCPD01gMO1HEMO@J1E?bC1?@FC?JA1PMVR@CDCJ1R?FDH1MN1DEC1HRFC?JHECCD1NMF1AMOF1cFMdCPD1eaM1G@CHDM>C1?HHGQ>VC>D0
=@@1HMOFPCHS1G>P@OJG>Q1AMOF1cFMdCPD1eaM1fG>?>PG?@1fMFVO@?H1HRFC?JHECCDS1HEMO@J1KC1PGDCJ1?PPMFJG>Q1DM1=c=1HDA@C0
t]44_v̂Yi8Ž36:v537;
eEC1NM@@MaG>Q1FCHMOFPCH1HORRMFD1AMOF1aMFI1M>1DEC1RFMdCPD
_Z]n:Y6<1cFMdCPD1eaM1fG>?>PG?@1=HHOVRTM>H1csf11
zHC1DEGH1JMPOVC>D1DM1EC@R1AMO1PMVR@CDC1DEGH1RFMdCPD0
_Z]n:Y6<1cFMdCPD1eaM1jOHG>CHH1‹RTM>H1GHD1csf11
zHC1DEGH1JMPOVC>D1DM1HC@CPD1AMOF1PEMHC>1KOHG>CHH1NMF1DEGH1RFMdCPD0
tu345v_895ƒv3v…8|:;_]vZ:<1CFQC>D1‹>@G>C1
zHC1DEGH1FCHMOFPC1DM1EC@R1AMO1PMVR@CDC1DEGH1RFMdCPD0
‘5l:_<1CFQC>D1‹>@G>C<1cOK@GP1pMVR?>A1fG>?>PG?@H1}’<’“~1
ˆ?DPE1DEGH1bGJCM1NFMV1DEC1†E?RGFM1GKF?FA1DM1@C?F>1VMFC1?KMOD1EMa1DM1?PPCHH1?>J1OHC1CFQC>D1‹>@G>C01=@DEMOQE1DEGH1bGJCM1HEMaH1G>NMFV?TM>1M>1DEC1”=H1CRMFDCJ1pOFFC>PAo1R?QC1aGDEG>1DEC1pMVR?>A
fG>?>PG?@H1D?KS1NMF1DEC1ROFRMHCH1MN1DEGH1PMOFHCS1DEC1KCHD1MRTM>1NMF1@MP?T>Q1L>?>PG?@1J?D?1P?>1KC1?PPCHHCJ1KA1P@GPIG>Q1M>1”†D?>J?FJGBCJo1KC>C?DE1DEC1”pMVR?>A1fG>?>PG?@Ho1D?K01eEGH1aG@@1?@@Ma1AMO1DM1?PPCHH1DEC
†D?>J?FJGBCJ1=
O?@1j?@?>PC1†ECCD0
���������������    

��
����������������������������������������� �!��"#��
#�������$$$�%��
����������&�%!�'���(�!��#)!��)�&�%����*����&����!�#�+��
�����,����������-&�%��)%.��,�/00-������,1)������-��������,234 ��5
6789:;<=>?@ABM(&#��
�������)��������#����*��#��N����M����������������
O8P:QDRA<6?A: XYZX[Z\X\] X̂ZX[Z\X\] X]ZX\Z\X\] X_Z\YZ\X\X X[Z\̀Z\X\X ]\Z\̀Z\X]a X_Z\aZ\X]a X[Z[XZ\X]a ]\Z\aZ\X]̀
[RSTU?RA:R
]8ATU?RA:R
]8ATU?RA:R
]8ACURR:9W; bJ6 bJ6 bJ6 bJ6 bJ6 bJ6 bJ6 bJ6 bJ6
OUS7ACD98D@7S?A:S I:8 I:8 I:8 I:8 I:8 I:8 I:8 I:8 I:8
JW?@: FGDU8?9S8 FGDU8?9S8 FGDU8?9S8 FGDU8?9S8 FGDU8?9S8 FGDU8?9S8 FGDU8?9S8 FGDU8?9S8 FGDU8?9S8
��#�-�&��#
�c)�d������
�e�f�f�fff ���0�f�fff ���fe0�fff �5�����fff �/�55��fff e�055�fff e���0�fff �f��f0�fff /�/���fff
��&��d�.��� �5�5���fff ����55�fff �/�f���fff ���e���fff �/��5��fff ����ff�fff ���e�5�fff �/���5�fff �f���5�fff
g�d�������� ��5
�fff ��/fe�fff ��/0f�fff ������fff ���5��fff ������fff ����e�fff ��
��fff ��5���fff
h�&�����
&�������&����
-���d��&��
��5e��fff ���f/�fff ��/�5�fff 5��5��fff ��0e��fff ��55/�fff /���e�fff ��/f0�fff 0�/�fff
��#���&)�����
������
05f�fff 0
�fff 0���fff 0���fff ��ff5�fff �50�fff ��f5��fff ������fff ��0�fff
�������#����*��
����
� � � � � � ��0���fff ��/ee�fff �
"�����&)�����
������
55��ee�fff 5��0���fff 5/�0�/�fff /��55f�fff 55���/�fff �����e�fff 5��5�f�fff 5/�����fff ����5��fff
    ���)&���-
��&�����
&�������&����
���00��fff �e�0�0�fff �������fff ����ef�fff �e�����fff �e��5��fff �������fff �/�5�5�fff 0�����fff
g�d���%���� /�f/��fff /�5f��fff /�f5��fff 5�e���fff 5��0f�fff 5�5���fff 5�0���fff /�f0f�fff ����f�fff
�����&������
.)�����
��-
�c)��%���
e/�f�5�fff e5�f5��fff e5�f���fff e���5f�fff ef�����fff �����f�fff ���/���fff �������fff ���50��fff
�&&)%)�����
�����&��������
�����&������
.)�����
��-
�c)��%���
5������fff 5e�0ee�fff 5e�50f�fff 5/�e5��fff 55���5�fff 55�f���fff 5��f00�fff 55��5��fff 5��fe��fff
    ��i����������
-���#��
���������.�*���
���j�&�����
���
�����-
������"����
�e�
�fff �e�����fff �e�e5��fff �e�/���fff �����e�fff �e�0�5�fff ���5e��fff �/�0���fff �/�5�e�fff
    ��j�&�����
���
����
�0�e�fff /�0���fff /��/��fff /�50f�fff 5���e�fff /�f�5�fff /�0�5�fff /��0/�fff /�55e�fff
h��� ��f���fff ��f���fff ��f���fff ��f�f�fff ��f���fff ��f���fff ����f�fff ����/�fff ���/��fff
    ��i����������
-���#��
�������������
5��5���fff 5���5��fff 5���e5�fff 5��0���fff 5������fff 5��0���fff 5��5���fff 5��f���fff �������fff
g����
�.��
�����������
���ef��fff �0���5�fff �0�e/��fff ����0��fff ���f5��fff ���ee��fff �����/�fff �e��0��fff e��/��fff

    �$�����.�� ����.��
���������������    

��
����������������������������������������� �!��"#��
#�������$$$�%��
����������&�%!�'���(�!��#)!��)�&�%����*����&����!�#�+��
�����,����������-&�%��)%.��,�/00-������,1)������-��������,234 ��5
6789:;<=>;7 ?@A?BAC?CD ?EA?BAC?CD ?DA?CAC?CD ?FAC@AC?C? ?BACGAC?C? DCACGAC?DH ?FACHAC?DH ?BAB?AC?DH DCACHAC?DG
B:I:;7: CLI
JK>:;7:
DM;:;7: B:I:;7: CLI
JK>:;7:
DM;:;7: B:I:;7: CLI
JK>:;7:
DM;:;7:
NK::7LOP QR= QR= QR= QR= QR= QR= QR= QR= QR=
SKIT;;KM QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I
N9LM9UTI>;7I V7M V7M V7M V7M V7M V7M V7M V7M V7M
RO>U7 WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM
Y���$��� ���05��ZZZ ���0[��ZZZ ���0ZZ�ZZZ ����55�ZZZ 0Z�5�Z�ZZZ 0Z�5�/�ZZZ ���0Z��ZZZ ���Z���ZZZ 5���0��ZZZ
\��&)�����
�������#����*��
����
� � � � � � �������ZZZ �5��0��ZZZ �
��#��������� 0��Z0�ZZZ 0�Z0��ZZZ 0�5/5�ZZZ 0�/5��ZZZ 0�����ZZZ 0�
5�ZZZ /��05�ZZZ ��5���ZZZ 5�/�/�ZZZ
"����������� �Z������ZZZ �ZZ���Z�ZZZ �Z��000�ZZZ �Z��[/��ZZZ �Z[���/�ZZZ �ZZ��/0�ZZZ �Z��/���ZZZ ��/�5/��ZZZ ����/��ZZZ
�&&�)���
����.���-
��#����&&�)��
���.�������
�0�5���ZZZ ���Z[��ZZZ �[�0/[�ZZZ �[��0[�ZZZ ����Z[�ZZZ �������ZZZ ���[/��ZZZ �Z��Z5�ZZZ �Z�[�[�ZZZ
)�������������
�*�.����$��

���0�ZZZ ���/5�ZZZ ��5���ZZZ �Z���/�ZZZ ���[�[�ZZZ �Z�Z�0�ZZZ �����5�ZZZ �����0�ZZZ 5�/0��ZZZ
��*�����
��]��)��-
��#���&)�����
���.�������
�5[0�ZZZ /�55��ZZZ /�5Z5�ZZZ 5��Z��ZZZ /�0���ZZZ ��Z�/�ZZZ /��5Z�ZZZ /��0��ZZZ 5�/5/�ZZZ
�̂�.��������#���
*�������
� � � � � � ��5�ZZZ /5/�ZZZ �
"�����&)�����
���.�������
���/�5�ZZZ �[�[/��ZZZ �[��/[�ZZZ 5Z�����ZZZ 5��/�5�ZZZ 5/�����ZZZ
���5�ZZZ
�5�[�ZZZ ���[���ZZZ
�%%��&���
�����
.����$��

� � � � 0�/05�ZZZ [��5/�ZZZ � � [���ZZZ
_!3!�-
)̀������
%���)%����%
�����
� � � � � � � � ����/��ZZZ
_!3!�������
����%������
�����
� � � �
��0��ZZZ 5��50Z�ZZZ � � �
����
a������������
"#�%��    ��b�
.����$��

� � � � � � � � ���[Z�ZZZ
�����"#�%�
    ��b�
.����$��

� � � � ���0��ZZZ ���/[�ZZZ � � �
c����

&)����&�
����%������
��.��-���#��
.����$��

� � � � ��/0��ZZZ ��Z���ZZZ � � 0���ZZZ
"����
.����$��

.�*����&)�����
�������
� � � � ���
[�ZZZ /0�Z���ZZZ � � �Z�[[��ZZZ
�̂����&)�����
���������*
.����$��

� � � � ���[�[�ZZZ �Z�Z�0�ZZZ � � 5�/0��ZZZ
2����$��
� �����Z�ZZZ �Z��Z5�ZZZ ���0�0�ZZZ �/�����ZZZ /����Z�ZZZ 50�Z���ZZZ 5[�5���ZZZ 5��0Z5�ZZZ �����[�ZZZ
��*�����
��&�%����(��
[�05��ZZZ [�0�/�ZZZ ���Z��ZZZ ��Z���ZZZ ���[��ZZZ 0�5[/�ZZZ �Z�/Z/�ZZZ ����Z0�ZZZ 5�����ZZZ
���������������    

��
����������������������������������������� �!��"#��
#�������$$$�%��
����������&�%!�'���(�!��#)!��)�&�%����*����&����!�#�+��
�����,����������-&�%��)%.��,�/00-������,1)������-��������,234 5�5
6789:;<=>;7 ?@A?BAC?CD ?EA?BAC?CD ?DA?CAC?CD ?FAC@AC?C? ?BACGAC?C? DCACGAC?DH ?FACHAC?DH ?BAB?AC?DH DCACHAC?DG
B:I:;7: CLI
JK>:;7:
DM;:;7: B:I:;7: CLI
JK>:;7:
DM;:;7: B:I:;7: CLI
JK>:;7:
DM;:;7:
NK::7LOP QR= QR= QR= QR= QR= QR= QR= QR= QR=
SKIT;;KM QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I QL>KIT;7I
N9LM9UTI>;7I V7M V7M V7M V7M V7M V7M V7M V7M V7M
RO>U7 WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM WX9KM>LIM
Y��&)�����
���.��������#���
*�������
� � � � � � ��5�5�ZZZ ��[���ZZZ �
��#������

���%����.�������
�[��/��ZZZ �[�[���ZZZ ����Z��ZZZ ���0���ZZZ �[���5�ZZZ �����0�ZZZ �Z��[��ZZZ ���0�/�ZZZ [�/���ZZZ
�����%�.��
���&���������
���������
��/���ZZZ ��/�Z�ZZZ ��55Z�ZZZ ���[��ZZZ ��Z�[�ZZZ ��Z���ZZZ 0�0���ZZZ ���Z5�ZZZ ����/�ZZZ
�%%������&\ �����/�ZZZ ���ZZZ�ZZZ �/�[[5�ZZZ �/�50[�ZZZ �/��5Z�ZZZ �5�����ZZZ �5���0�ZZZ �5�/���ZZZ 5[�����ZZZ
��������
������

��&&)%)�����
��*�&���
Z�5���ZZZ 5��5[��ZZZ 50�/�[�ZZZ 5��ZZ/�ZZZ /5�����ZZZ /5��Z��ZZZ /��50��ZZZ /������ZZZ 0/�00��ZZZ
��\���]��)�
��̂)��%����
*�����]���%����
� � � �[�ZZZ� � � ���ZZZ� �/�ZZZ� �
��\���]��)�
��̂)��%����
*���#��
��
���5�ZZZ� � �5�/�ZZZ� � ����ZZZ ���ZZZ� 55�ZZZ /0�ZZZ ��0�ZZZ
��\���]��)�
��̂)��%����
� ���/�ZZZ� � � � � � � �
_���&�
��'��
��������-
����������%���
%���&��
�(�����
�[�����ZZZ� �[�00��ZZZ� ���Z���ZZZ� ���/[��ZZZ� ����[[�ZZZ� ���[5��ZZZ� �5�����ZZZ� �5�����ZZZ� �5��/��ZZZ�
�̀���

&)����&�
������������-
��#��
�&&)%)�����
&�%���#����]�
��&�%��������
�����ZZZ� �0�5�ZZZ� ��/��ZZZ� ����/��ZZZ� �����5�ZZZ� �00��ZZZ� ���0�ZZZ� �[���ZZZ� �[[5�ZZZ�
�&&)%)�����
��#��
&�%���#����]�
��&�%��������
���05��ZZZ� �����0�ZZZ� �0��/��ZZZ� �[�[���ZZZ� �[�[5��ZZZ� �[��55�ZZZ� �5�����ZZZ� �5��0[�ZZZ� �5��0��ZZZ�
3#���#������a
�b)�����).������
� � � � � � � �Z�0/��ZZZ �����Z/�ZZZ
"����)������&\�
���&���
�Z��ZZZ �Z��ZZZ �Z��ZZZ �Z��ZZZ �Z��ZZZ �Z��ZZZ �Z��ZZZ �Z��ZZZ [���00�ZZZ
"�����������
�#���#������a
�b)���
0[��/��ZZZ 0���/Z�ZZZ 0/�Z���ZZZ 0��0[[�ZZZ �Z�/Z��ZZZ 0������ZZZ �Z�/���ZZZ 0���50�ZZZ �Z�5�[�ZZZ
Y��&���������
���������
�50��ZZZ /��/[�ZZZ /�[���ZZZ /�����ZZZ /�/�Z�ZZZ ��Z�[�ZZZ ��00/�ZZZ �/�/Z��ZZZ /�Z���ZZZ
"������b)��� �������ZZZ 0���0[�ZZZ 00���0�ZZZ �Z�/[5�ZZZ �/�0���ZZZ �/���5�ZZZ �[�5�[�ZZZ �Z/�55��ZZZ �/�5�5�ZZZ

RATIOS
    ACCOUNTING & FINANCIAL RATIOS
                        Amount in thousands
        CURRENT RATIO (Cu
ent Assets / Cu
ent Liabilities)                                TOTAL ASSET TURNOVER RATIO (Total Revenue / Total Assets)
        Cu
ent Assets         XXXXXXXXXX                        Total Revenue         XXXXXXXXXX
        Cu
ent Liabilities         XXXXXXXXXX         XXXXXXXXXX                Total Assets         XXXXXXXXXX         XXXXXXXXXX
        WORKING CAPITAL (Cu
ent Assets - Cu
ent Liabilities)                                 FINANCIAL LEVERAGE (Total Assets / Shareholder's Equity)
        Cu
ent Assets         XXXXXXXXXX                        Total Assets         XXXXXXXXXX
        Cu
ent Liabilities         XXXXXXXXXX        6553000                Shareholder's Equity         XXXXXXXXXX         XXXXXXXXXX
        DEBT RATIO (Total Debt / Total Assets)                                NET PROFIT MARGIN (Net Income / Total Revenue)
        Total Debt         XXXXXXXXXX                        Net Income        918000
        Total Assets         XXXXXXXXXX         XXXXXXXXXX                Total Revenue         XXXXXXXXXX         XXXXXXXXXX
        EARNINGS PER SHARE (Net Income / Weighted Average Common Shares Outstanding)                                RETURN ON ASSETS (Net Income / Total Assets)
        Net Income        918000                        Net Income        918000
        Shares Outstanding        1818000         XXXXXXXXXX                Total Assets         XXXXXXXXXX         XXXXXXXXXX
        PRICE EARNINGS RATIO (Share Price (end of quarter / EPS)                                RETURN ON EQUITY (Net Income - Prefe
ed Dividends / Shareholder's Equity)
        Stock Price         177.11                        NI - Pref. Div.        918000
        EPS         XXXXXXXXXX         XXXXXXXXXX                Shareholder's Equity         XXXXXXXXXX         XXXXXXXXXX
Monthly
                Time Value of Money - Monthly Compounding
    Rate of Return            Year 1
    Initial Investment            Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 2
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 3
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 4
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 5
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 6
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 7
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 8
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 9
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Year 10
                Month    1    2    3    4    5    6    7    8    9    10    11    12
                Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
Annual
                Time Value of Money - Annual Compounding
    Rate of Return            Year     1    2    3    4    5    6    7    8    9    10
    Initial Investment            Interest    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
                Investment Value    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
PV
    Time Value of Money - Present Value Annuity
    Number of Years
    Rate of Return            $0.00
    Payment
FV
    Time Value of Money - Future Value Annuity
    Number of Years
    Rate of Return            $0.00
    Payment
PV - Lump Sum
    Time Value of Money - Present Value of Lump Sum
    Rate
    Years            $0.00
    Initial Investment
FV - Lump Sum
    Time Value of Money - Future Value of Lump Sum
    Rate
    Years            $0.00
    Initial Investment
NPV
    Net Present Value (NPV) Calculato
    Building
    Initial Investment                            Year    1    2    3    4    5    6    7    8    9    10
    Annual Cash Inflows                            Cash Flows    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
    Discount Rate            NPV =     $0            Year    11    12    13    14    15    16    17    18    19    20
    Number of Years                            Cash Flows    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
    Salvage Value
    Equipment
    Initial Investment                            Year    1    2    3    4    5    6    7    8    9    10
    Annual Cash Inflows                            Cash Flows    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
    Discount Rate            NPV =     $0            Year    11    12    13    14    15    16    17    18    19    20
    Number of Years                            Cash Flows    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
    Salvage Value
    Bonds
    Initial Investment
    Annual Cash Inflows
    Discount Rate            NPV =     $0            Year    1    2    3    4    5    6    7    8    9    10
    Number of Years                            Cash Flows    $0    $0    $0    $0    $0    $0    $0    $0    $0    $0
    Principal Returned

FIN 320 Project Two Financial Analyst Report
FIN 320 Project Two Financial Analyst Report
[Note: To complete this template, replace the
acketed text with your own content. Remove this note before you submit your report.]
Financial Analysis, Financial Evaluation, and Financial Recommendation(s)
Financial Analysis
Financial Calculations:
Using the most cu
ent quarter’s financial statements for your chosen business and the
Financial Formulas spreadsheet, calculate the financial formulas below to assess the
usiness’s financial health.
Working capital:
[Write the result of the calculation and what it says about the company’s health.]
Cu
ent ratio:
[Write the result of the calculation and what it says about the company’s health.]
Debt ratio:
[Write the result of the calculation and what it says about the company’s health.]
Earnings per share:
[Write the result of the calculation and what it says about the company’s health.]
Price/earnings ratio:
[Write the result of the calculation and what it says about the company’s health.]
Total asset turnover ratio:
[Write the result of the calculation and what it says about the company’s health.]
Financial leverage:
[Write the result of the calculation and what it says about the company’s health.]
Net profit margin:
[Write the result of the calculation and what it says about the company’s health.]
Return on assets:
[Write the result of the calculation and what it says about the company’s health.]
Return on equity:
[Write the result of the calculation and what it says about the company’s health.]
Working Capital Management:
[In one paragraph, explain the impact of working capital management on the business’s operations. Provide examples to support your claims.]
Bond Investment:
[In one paragraph, analyze the risks and benefits of the business choosing to invest in a
corporate bond, including the necessary ethical considerations, appropriate calculations, and examples to support your analysis.]
Capital Equipment:
[In one paragraph, analyze the risks and benefits of the business choosing to invest in capital equipment, including the necessary ethical considerations, appropriate calculations, and examples to support your analysis.]
Capital Lease:
[In one paragraph, analyze the risks and benefits of the business choosing to purchase a capital lease, including the necessary ethical considerations, appropriate calculations, and examples to support your analysis.]
Financial Evaluation
In this section of the report, you will evaluate the three available financial options for the business and recommend which option(s) are the best for the business to choose.
1. Financing:
[In one paragraph, explain how a business finances its operations and expansion.]
Bond Investment:
[In one paragraph, write your assessment on the appropriateness of a bond investment as an option for the business’s financial health, using your financial analysis and other financial information to support your claims.]
Capital Equipment:
[In one paragraph, write your assessment on the appropriateness of a capital equipment investment as an option for the business’s financial health, using your financial analysis and other financial information to support your claims.]
Capital Lease:
[In one paragraph, write your assessment on the appropriateness of a capital lease purchase as an investment option for the business’s financial health, using your financial analysis and other financial information to support your claims.]
Short-Term Financing:
[In one paragraph, explain how potential short-term financing sources could help the business raise needed funds for improving its financial health. Base your response on the business’s cu
ent financial information.]
Future Financial Considerations:
[In one paragraph, describe the business’s likely future financial performance based on its cu
ent financial well-being and risk level. Use financial information to support your claims.]
Financial Recommendation(s)
[In 1 to 2 paragraphs, recommend the most appropriate financing option(s) based on the business’s financial health, and include a rationale for why the option(s) are the best.]
3
Answered 2 days After Dec 13, 2021

Solution

Sumit answered on Dec 15 2021
131 Votes
FIN 320 Project Two Financial Analyst Report
FIN 320 Project Two Financial Analyst Report
Financial Analysis, Financial Evaluation, and Financial Recommendation(s)
Financial Analysis
Financial Calculations:
Using the most cu
ent quarter’s financial statements for your chosen business and the
Financial Formulas spreadsheet, calculate the financial formulas below to assess the
usiness’s financial health.
Working capital:
The Working Capital of the company is $6,553,000. The company has adequate working capital to manage the day-to-day operations of the company.
Cu
ent ratio:
The Cu
ent Ratio of the company is 1.24. This indicates that the company has adequate cu
ent assets to pay the cu
ent liabilities of the company.
Debt ratio:
The Debt Ratio of the company is 0.367. This indicates that the company has sufficient assets to pay the debt of the company and therefore the risk level of the company is low
Earnings per share:
The Earnings per Share of the company is 0.51. This indicates that the company is earning $0.51 per share outstanding of the company.
Price/earnings ratio:
The P/E Ratio of the company is 350.75. This indicates the number of times the Cu
ent Market Price of the company is trading with to the EPS of the company.
Total asset turnover ratio:
The Total Assets Turnover of the company is 0.084. The ratio being less than 1 indicates that the company is not using the assets efficiently.
Financial leverage:
The Financial Leverage of the company is 2.219. The ratio being more than 2 indicates that the company is using less debt to finance the assets of the company and therefore the company is not using leverage for its advantage.
Net profit margin:
The Net...
SOLUTION.PDF

Answer To This Question Is Available To Download

Related Questions & Answers

More Questions »

Submit New Assignment

Copy and Paste Your Assignment Here